Japan colorectal tumor prevention study: clinical trial by low-dose aspirin - Japan colorectal tumor prevention study: clinical trial by low-dose aspirin (J-CAPP Study 2)

Kyoto Prefectural University of Medicine0 个研究点目标入组 7,000 人开始时间: 2015年8月21日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•# Patients with a medical history of submucosal (sm) or deeper colorectal cancer. # Patients with familial adenomatous polyposis or Lynch syndrome. # Patients currently taking antithrombotics such as Bayaspirin, Panaldine, Warfarin and Persantin etc. # Patients with known allergy to aspirin. # Patients who have undergone colorectal resection (those who have undergone appendectomy are allowed to participate in the study). # Women who are or may be pregnant during the study period. # Patients with a history of treatment of gastric or duodenal ulcer (those with successful eradication of Helicobacter pylori and ulcer resolution at S2 are allowed to participate in the study) # Patients with inflammatory bowel disease (ulcerative colitis, Crohn syndrome), bleeding diverticulosis, bleeding gastritis. # Patients with bleeding tendency, a platelet count of < 100,000 /mm3, or with abnormal prothrombin time. # Patients with any existing cancer at the time of participation in the study. # Patients currently taking anticancer drugs. # Patients currently taking NSAIDs at least 3 times weekly, for example, as a analgesic.

发起方